Riskpilot← Back to searchSign inGet full accessNya Närvården NNV AB
ABActiveOrg 5568079239General medical practice activities · NACE 8621Est. 201020 employees
Revenue 2025
SEK 27,9M
-12% vs 2024
EBITDA margin
32.1%
+46% vs 2024
Equity ratio
62.7%
Financial strength
Net profit 2025
SEK 7,1M
+45% vs 2024
| Revenue | SEK 27,9M | -12% |
| EBITDA | SEK 9M | +46% |
| Net profit | SEK 7,1M | +45% |
| Total assets | SEK 11,4M | +39% |
| Equity | SEK 7,1M | +45% |
| Employees | 20 | — |
Legal name
Nya Närvården NNV AB
Org number
5568079239
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 maj 2010
Share capital
SEK 50 000
Employees
20 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva primärvård, konsultverksamhet inom sjukvård, handel med värdepapper och därmed förenlig verksamhet.
Address
Email
jennifer.rudfjall@nnv.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 33 218 | 34 124 | 33 229 | 31 681 | 27 908 |
| Staff expenses | — | −11 501 | — | −11 834 | — |
| EBITDA | 4 195 | 7 404 | 9 009 | 6 122 | 8 963 |
| Depreciation & amort. | −49 | −47 | −9 | −5 | −8 |
| EBIT | 4 146 | 7 357 | 9 000 | 6 116 | 8 955 |
| Net financials | −6 | −70 | −85 | 12 | 14 |
| Profit before tax | 3 141 | 3 300 | 2 693 | 6 134 | 8 921 |
| Tax | −1 114 | −693 | −543 | −1 260 | −1 839 |
| Net profit | 2 027 | 2 607 | 2 150 | 4 874 | 7 082 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 758 | 8 896 | 7 480 | 8 180 | 11 383 |
| Equity | 2 086 | 2 662 | 2 212 | 4 926 | 7 138 |
| Long-term debt | 0 | 135 | 2 026 | 0 | 0 |
| Short-term debt | 3 641 | 4 079 | 3 232 | 3 249 | 4 191 |
| Total debt | 3 641 | 4 215 | 5 258 | 3 249 | 4 191 |
EBITDA margin
32.1%
This company
15.8%
Market median
+103% vs market
20212025
Equity ratio
62.7%
This company
38.2%
Market median
+64% vs market
20212025
Return on equity
99.2%
This company
18.4%
Market median
+439% vs market
20212025
Net profit margin
25.4%
This company
8.1%
Market median
+214% vs market
20212025
Asset turnover
2.45×
This company
1.12×
Market median
+119% vs market
20212025
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UH Chief Auditor | Chief Auditor | 2026 |
| Former (1) | ||
MS Chief Auditor | Chief Auditor | 2025 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2025 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 60% | 60% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lihabo Holding AB
Nya Närvården NNV AB Board members of Nya Närvården NNV AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulrika Helena Huss | Chief Auditor | 0 companies |
| Matilda Sang Yee Holmqvist | Chief Auditor | 0 companies |
| Per Anders Robin Rudfjäll | Deputy Board Member | 0 companies |
| Lisa Katrine Boberg | Deputy Board Member | 0 companies |
| Sara Jennifer Rudfjäll | Chairman | 0 companies |
| Hans Christer Boberg | Board of Directors | 0 companies |